Vietnam-focused private equity firm Mekong Capital said on Monday it has successfully divested the entire 24.99 per cent holding in pharmaceutical major Traphaco JSC for a total consideration of more than $64.5 million.
Continue reading this story with a subscription to DealStreetAsia.
Unlock your competitive advantage in a rapidly evolving scape. Our packages come with exclusive access to archives, content, data, discount on summit tickets & more. Be a part of our growing community now.